On the other hand, activation of AMPK by metformin can inhibit abnormal extracellular matrix remodeling in adipose tissue and improve insulin resistance in obesity [106], and can exert anti-inflammatory effects by inhibiting intracellular fatty acid synthesis in macrophages [107–110]. Here, PRKAA1 is linked to Insulin resistance.